Compare VTRS & HPQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTRS | HPQ |
|---|---|---|
| Founded | 1961 | 1939 |
| Country | United States | United States |
| Employees | 30000 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2B | 17.3B |
| IPO Year | 2019 | 2002 |
| Metric | VTRS | HPQ |
|---|---|---|
| Price | $14.78 | $19.87 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 12 |
| Target Price | $13.50 | ★ $21.42 |
| AVG Volume (30 Days) | 8.0M | ★ 16.1M |
| Earning Date | 05-07-2026 | 05-27-2026 |
| Dividend Yield | 3.24% | ★ 6.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.58 |
| Revenue | $14,299,900,000.00 | ★ $55,295,000,000.00 |
| Revenue This Year | $4.41 | $3.10 |
| Revenue Next Year | $1.96 | $0.39 |
| P/E Ratio | ★ N/A | $34.13 |
| Revenue Growth | N/A | ★ 3.24 |
| 52 Week Low | $8.19 | $17.56 |
| 52 Week High | $16.47 | $29.55 |
| Indicator | VTRS | HPQ |
|---|---|---|
| Relative Strength Index (RSI) | 60.97 | 54.11 |
| Support Level | $12.90 | $18.00 |
| Resistance Level | $15.22 | $20.09 |
| Average True Range (ATR) | 0.40 | 0.75 |
| MACD | 0.11 | 0.05 |
| Stochastic Oscillator | 75.68 | 53.04 |
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
HP (formerly Hewlett-Packard) is a behemoth in the PC and printing markets. It has focused on these markets since it exited IT infrastructure in 2015 with the split from Hewlett Packard Enterprise. HP focuses on the commercial market, but maintains sales of consumer devices and printers. The firm has a broad and global customer base, with only one third of sales coming from the US. HP completely outsources manufacturing and relies heavily on channel partners for its sales and marketing.